Key facts
- This page summarizes Lance Willsey's Form 4 filing for EXELIXIS, INC. (EXEL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 May 2022, 20:10.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.47 to $19.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
Footnote F2
The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015.